Georgiamune has raised $75M in total funding. Backed by General Catalyst, Parker Institute for Cancer Immunotherapy.
Georgiamune funding overview
Georgiamune has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Georgiamune runs through 2023; nothing later has been disclosed. Investors on record include General Catalyst, Parker Institute for Cancer Immunotherapy. 2 distinct backers are named across the disclosed rounds.
Georgiamune at a glance
Total raised
$75M
Latest round date
August 2023
Notable investors
General Catalyst, Parker Institute for Cancer Immunotherapy
Frequently asked about Georgiamune funding
How much has Georgiamune raised?
Georgiamune has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Georgiamune?
General Catalyst, Parker Institute for Cancer Immunotherapy are named among the investors backing Georgiamune.
What was the latest Georgiamune funding round?
No round stage has been disclosed for Georgiamune.
Where is Georgiamune based?
No headquarters location is disclosed for Georgiamune.
When did Georgiamune last raise?
The last disclosed Georgiamune round closed in August 2023.
Totals shown for Georgiamune aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
